{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:36:21Z","timestamp":1787668581349,"version":"build-2736575974"},"reference-count":40,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T00:00:00Z","timestamp":1700697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Massachusetts Life Science Center (MLSC) USA"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antioxidants"],"abstract":"<jats:p>Background: Preeclampsia (PE) is a hypertensive disorder of pregnancy that is associated with substantial morbidity and mortality for the mother and fetus. Reduced nitric oxide bioavailability and oxidative stress contribute to the maternal and fetal pathophysiology of PE. In this study, we evaluated the efficacy of a novel dual-function nitric oxide donor\/redox modulator, AKT-1005, in reducing PE symptoms in a mouse model of PE. Method: The potential therapeutic effect of AKT-1005 was tested in an animal model of Ad.sFlt-1-induced hypertension, proteinuria and glomerular endotheliosis, a model of PE. Pregnant Ad.sFlt-1-overexpressing CD1 mice were randomized into groups administered AKT-1005 (20 mg\/kg) or a vehicle using a minipump on gd11 of pregnancy, and the impact on blood pressure and renal and placental damage were assessed. Results: In healthy female mice, ex vivo treatment of resistance vessels with AKT-1005 induced vasorelaxation, and 6 days of treatment in vivo did not significantly alter blood pressure with or without pregnancy. When given for 6 days during pregnancy along with Ad.sFlt-1-induced PE, AKT-1005 significantly increased plasma nitrate levels and reduced hypertension, renal endotheliosis and plasma cystatin C. In the placenta, AKT-1005 improved placental function, with reduced oxidative stress and increased endothelial angiogenesis, as measured by CD31 staining. As such, AKT-1005 treatment attenuated the Ad.sFlt-1-induced increase in placental and free plasma soluble endoglin expression. Conclusions: These data suggest that AKT-1005 significantly attenuates the sFlt-1-induced PE phenotypes by inhibiting oxidative stress, the anti-angiogenic response, and increasing NO bioavailability. Additional research is warranted to investigate the role of AKT-1005 as a novel therapeutic agent for vascular disorders such as preeclampsia.<\/jats:p>","DOI":"10.3390\/antiox12122036","type":"journal-article","created":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T06:06:23Z","timestamp":1700719583000},"page":"2036","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A Novel Dual-Function Nitric Oxide Donor Therapy for Preeclampsia\u2014A Proof-of-Principle Study in a Murine Model"],"prefix":"10.3390","volume":"12","author":[{"given":"Diana","family":"Pintye","sequence":"first","affiliation":[{"name":"Department of Medicine, Beth Israel Lahey Health, Boston, MA 02215, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9170-4331","authenticated-orcid":false,"given":"R\u00e9ka E.","family":"Sziva","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Semmelweis University, 1085 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren A.","family":"Biwer","sequence":"additional","affiliation":[{"name":"Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA 02111, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esilida Sula","family":"Karreci","sequence":"additional","affiliation":[{"name":"Department of Medicine, Beth Israel Lahey Health, Boston, MA 02215, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonako","family":"Jacas","sequence":"additional","affiliation":[{"name":"Department of Medicine, Beth Israel Lahey Health, Boston, MA 02215, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxim","family":"Mastyugin","sequence":"additional","affiliation":[{"name":"Department of Chemistry, UMass Boston, Boston, MA 02125, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"T\u00f6r\u00f6k","sequence":"additional","affiliation":[{"name":"Department of Chemistry, UMass Boston, Boston, MA 02125, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett C.","family":"Young","sequence":"additional","affiliation":[{"name":"Department of OB\/GYN, Beth Israel Lahey Health, Boston, MA 02215, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash","family":"Jagtap","sequence":"additional","affiliation":[{"name":"Akkadian Therapeutics, Stoneham, MA 02180, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garry J.","family":"Southan","sequence":"additional","affiliation":[{"name":"Akkadian Therapeutics, Stoneham, MA 02180, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris Z.","family":"Jaffe","sequence":"additional","affiliation":[{"name":"Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA 02111, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4540-5728","authenticated-orcid":false,"given":"Zsuzsanna K.","family":"Zsengell\u00e9r","sequence":"additional","affiliation":[{"name":"Department of Medicine, Beth Israel Lahey Health, Boston, MA 02215, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,11,23]]},"reference":[{"key":"ref_1","unstructured":"American College of Obstetricians and Gynecologists (2019). ACOG Practice Bulletin No. 202: Gestational Hypertension and Preeclampsia. Obstet. Gynecol., 133, e1\u2013e25."},{"key":"ref_2","first-page":"533","article-title":"Pregnancy-related mortality from preeclampsia and eclampsia","volume":"97","author":"MacKay","year":"2001","journal-title":"Obstet. Gynecol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0140-6736(10)60279-6","article-title":"Pre-eclampsia","volume":"376","author":"Steegers","year":"2010","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/S0140-6736(06)68397-9","article-title":"WHO analysis of causes of maternal death: A systematic review","volume":"367","author":"Khan","year":"2006","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ajog.2017.04.032","article-title":"Short-term costs of preeclampsia to the United States health care system","volume":"217","author":"Stevens","year":"2017","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J. Clin. Investig."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJMoa055352","article-title":"Soluble endoglin and other circulating antiangiogenic factors in preeclampsia","volume":"355","author":"Levine","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/CIRCRESAHA.118.313276","article-title":"Preeclampsia: Pathophysiology, Challenges, and Perspectives","volume":"124","author":"Rana","year":"2019","journal-title":"Circ. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nm1429","article-title":"Soluble endoglin contributes to the pathogenesis of preeclampsia","volume":"12","author":"Venkatesha","year":"2006","journal-title":"Nat. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ajpath.2018.09.007","article-title":"AP39, a Modulator of Mitochondrial Bioenergetics, Reduces Antiangiogenic Response and Oxidative Stress in Hypoxia-Exposed Trophoblasts: Relevance for Preeclampsia Pathogenesis","volume":"189","author":"Covarrubias","year":"2019","journal-title":"Am. J. Pathol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0143-4004(98)90018-2","article-title":"Placental mitochondria as a source of oxidative stress in pre-eclampsia","volume":"19","author":"Wang","year":"1998","journal-title":"Placenta"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1161\/HYPERTENSIONAHA.118.11290","article-title":"Role of Mitochondrial Dysfunction and Reactive Oxygen Species in Mediating Hypertension in the Reduced Uterine Perfusion Pressure Rat Model of Preeclampsia","volume":"72","author":"Vaka","year":"2018","journal-title":"Hypertension"},{"key":"ref_14","first-page":"79","article-title":"Oxidative stress causes vascular dysfunction in the placenta","volume":"9","author":"Myatt","year":"2000","journal-title":"J. Matern. Fetal Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00418-004-0677-x","article-title":"Oxidative stress in the placenta","volume":"122","author":"Myatt","year":"2004","journal-title":"Histochem. Cell Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1016\/j.placenta.2009.12.021","article-title":"Review: Reactive oxygen and nitrogen species and functional adaptation of the placenta","volume":"31","author":"Myatt","year":"2010","journal-title":"Placenta"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Mar\u00edn, R., Chiarello, D.I., Abad, C., Rojas, D., Toledo, F., and Sobrevia, L. (2020). Oxidative stress and mitochondrial dysfunction in early-onset and late-onset preeclampsia. Biochim. Biophys. Acta Mol. Basis Dis., 1866.","DOI":"10.1016\/j.bbadis.2020.165961"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1136\/bmj.p1594","article-title":"Pre-eclampsia: FDA approves blood test to identify pregnant women at risk","volume":"382","author":"Tanne","year":"2023","journal-title":"BMJ"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1177\/1753944708092277","article-title":"The role of the L-arginine-nitric oxide pathway in preeclampsia","volume":"2","author":"Arenas","year":"2008","journal-title":"Ther. Adv. Cardiovasc. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0002-9378(98)70437-5","article-title":"Plasma concentrations of asymmetric dimethylarginine, a natural inhibitor of nitric oxide synthase, in normal pregnancy and preeclampsia","volume":"178","author":"Holden","year":"1998","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1046\/j.1440-1681.2003.03844.x","article-title":"Placental endothelial nitric oxide synthase localization and expression in normal human pregnancy and pre-eclampsia","volume":"30","author":"Orange","year":"2003","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1053\/plac.1999.0428","article-title":"Expression of endothelial nitric oxide synthase by extravillous trophoblast cells in the human placenta","volume":"21","author":"Martin","year":"2000","journal-title":"Placenta"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/BF00318873","article-title":"Physiological dilation of uteroplacental arteries in the guinea pig depends on nitric oxide synthase activity of extravillous trophoblast","volume":"282","author":"Nanaev","year":"1995","journal-title":"Cell Tissue Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1471-0528.1995.tb11428.x","article-title":"Nitric oxide synthase activities in placental tissue from normotensive, pre-eclamptic and growth retarded pregnancies","volume":"102","author":"Morris","year":"1995","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"909","DOI":"10.2353\/ajpath.2007.060665","article-title":"Glyceryl trinitrate inhibits hypoxia\/reoxygenation-induced apoptosis in the syncytiotrophoblast of the human placenta: Therapeutic implications for preeclampsia","volume":"170","author":"Belkacemi","year":"2007","journal-title":"Am. J. Pathol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1016\/j.ajpath.2011.02.013","article-title":"Glyceryl trinitrate inhibits hypoxia-induced release of soluble fms-like tyrosine kinase-1 and endoglin from placental tissues","volume":"178","author":"Barsoum","year":"2011","journal-title":"Am. J. Pathol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1161\/01.HYP.0000119192.32360.a9","article-title":"L-arginine attenuates hypertension in pregnant rats with reduced uterine perfusion pressure","volume":"43","author":"Alexander","year":"2004","journal-title":"Hypertension"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"R259","DOI":"10.1152\/ajpregu.00319.2011","article-title":"L-arginine supplementation abolishes the blood pressure and endothelin response to chronic increases in plasma sFlt-1 in pregnant rats","volume":"302","author":"Murphy","year":"2012","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Pintye, D., Sziva, R.E., Mastyugin, M., Young, B.C., Jacas, S., T\u00f6r\u00f6k, M., Salahuddin, S., Jagtap, P., Southan, G.J., and Zsengell\u00e9r, Z.K. (2023). A Novel Dual-Function Redox Modulator Relieves Oxidative Stress and Anti-Angiogenic Response in Placental Villus Explant Exposed to Hypoxia-Relevance for Preeclampsia Therapy. Biology, 12.","DOI":"10.3390\/biology12091229"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1161\/HYPERTENSIONAHA.120.16911","article-title":"Mineralocorticoid and Estrogen Receptors in Endothelial Cells Coordinately Regulate Microvascular Function in Obese Female Mice","volume":"77","author":"Biwer","year":"2021","journal-title":"Hypertension"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e96272","DOI":"10.1172\/jci.insight.96272","article-title":"Endothelial cell Pannexin1 modulates severity of ischemic stroke by regulating cerebral inflammation and myogenic tone","volume":"3","author":"Good","year":"2018","journal-title":"JCI Insight"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1172\/JCI83918","article-title":"Soluble fms-like tyrosine kinase 1 promotes angiotensin II sensitivity in preeclampsia","volume":"126","author":"Burke","year":"2016","journal-title":"J. Clin. Investig."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1681\/ASN.2013030291","article-title":"Hydrogen sulfide attenuates sFlt1-induced hypertension and renal damage by upregulating vascular endothelial growth factor","volume":"25","author":"Holwerda","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1369\/0022155416660291","article-title":"The Use of Cytochrome C Oxidase Enzyme Activity and Immunohistochemistry in Defining Mitochondrial Injury in Kidney Disease","volume":"64","author":"Rosen","year":"2016","journal-title":"J. Histochem. Cytochem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e158346","DOI":"10.1172\/JCI158346","article-title":"Impaired renal reserve contributes to preeclampsia via the kynurenine and soluble fms-like tyrosine kinase 1 pathway","volume":"132","author":"Dupont","year":"2022","journal-title":"J. Clin. Investig."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"ACOG Committee on Obstetric Practice (2002). ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstet. Gynecol., 99, 159\u2013167.","DOI":"10.1016\/S0029-7844(01)01747-1"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"American College of Obstetricians and Gynecologists (2019). ACOG Practice Bulletin No. 203: Chronic Hypertension in Pregnancy. Obstet. Gynecol., 133, e26\u2013e50.","DOI":"10.1097\/AOG.0000000000003020"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0002-9378(99)70314-5","article-title":"A randomized, double-blind trial of oral nifedipine and intravenous labetalol in hypertensive emergencies of pregnancy","volume":"181","author":"Vermillion","year":"1999","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Pintye, D., Sziva, R.E., Mastyugin, M., T\u00f6r\u00f6k, M., Jacas, S., Lo, A., Salahuddin, S., and Zsengell\u00e9r, Z.K. (2023). Nitroxide-HMP-Protects Human Trophoblast HTR-8\/SVneo Cells from H2O2-Induced Oxidative Stress by Reducing the HIF1A Signaling Pathway. Antioxidants, 12.","DOI":"10.3390\/antiox12081578"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1161\/CIRCRESAHA.122.321228","article-title":"Smooth Muscle Mineralocorticoid Receptor Promotes Hypertension after Preeclampsia","volume":"132","author":"Biwer","year":"2023","journal-title":"Circ. Res."}],"container-title":["Antioxidants"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3921\/12\/12\/2036\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:28:14Z","timestamp":1760131694000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3921\/12\/12\/2036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,23]]},"references-count":40,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["antiox12122036"],"URL":"https:\/\/doi.org\/10.3390\/antiox12122036","relation":{},"ISSN":["2076-3921"],"issn-type":[{"value":"2076-3921","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,23]]}}}